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Abstract
Background: The liver is the most sensitive and main target organ of pesticide toxicity and damage, they play an
essential role in metabolism and detoxification of pesticides. Due to these functions, hepatotoxicity continues to be
among the main threats to public health, and they remain problems throughout the world. Therefore, the present
study was designed to evaluate the antioxidant and hepatoprotective effects of Cedrelopsis grevei leaves against
cypermethrin (Cyp) induced oxidative stress and liver damage in male mice.
Methods: The extracts were subjected to different analyses (phenolics, tannin, flavonoids, antioxidant activity and
reducing power assays). For hepatoprotective evaluation, male mice were daily exposed to Cyp and/or C. grevei by
gavages for 28 days. Hepatoprotective effects were demonstrated by significant alterations in serum liver dysfunction
biomarker enzymes, liver lipid peroxidation and antioxidant enzymes.
Results: The antioxidant activity of C. grevei methanolic extract was the highest with an IC50 < 225 μg/ml by DPPH
assay. The high dose of methanolic extract (300 mg/kg. b.wt.) was effective to attenuate the perturbations in the tested
enzymes. Histopathological examination in the liver tissue of those mice, demonstrated that a co-administration of
methanolic extract (150 & 300 mg/kg/day) showed marked improvement in its histological structure in comparison to
Cyp-treated group alone and represented by nil to moderate degree in inflammatory cells.
Conclusions: In view of the data of the present study, it can deduce that cypermethrin caused oxidative damage and
liver dysfunction in male mice. C. grevei extract has protective effects on cypermethrin-induced lipid peroxidation,
oxidative stress and liver damage. Results indicated that administration of C. grevei is useful, easy, and economical
to protect humans against pesticide toxicity. The results presented here can be considered as the first
information on the hepatoprotective and antioxidant properties of C. grevei extracts. In a future study, we will
identify and
investigate the components responsible for the hepatoprotective and antioxidant activities of C. grevei.
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Background
Pesticides have been applied in agriculture and household
to protect plants, animals and human from insects and
vector diseases. The negligent and random uses of pesti-
cides can cause environmental damage, food, water con-
tamination, and health problems (e.g. cancer, nerve disease,
birth defects). Cypermethrin (Cyp), a class II pyrethroid
pesticide, first synthesized in 1974, widely used to control
many pest species in agriculture, animal breeding and the
household [1]. It has been reported that Cyp residues were
found in the air, on walls and furniture after three months
of household treatments [2]. Cyp was accumulated in adi-
pose tissue, brain and liver of rats [3, 4] and has hepato-
toxic potential in rodents [2, 5]. It crosses the blood–brain
barrier and induces neurotoxicity and motor deficits [6].
However, due to the low toxicity of pyrethroids, persistence
of these insecticides in mammalian tissues may be danger-
ous [3].
In fact, one possible mechanism of pesticide-induced
toxicity is the production of reactive oxygen species (ROS)
in the cell. ROS can alter oxidant/prooxidants statues and
antioxidant defense system by increasing lipid peroxidation
(LPO) and depleting the antioxidants in cell (enzymatic
and non-enzymatic) which leading to a condition of oxida-
tive stress [7]. It has been reported that ROS were involved
in the toxicity of organophosphate insecticides (OPIs) such
as chlorpyrifos [7] and pyrethroid insecticides such as
prallethrin [8, 9] and a positive correlation with the liver
damage has been reported. ROS, especially superoxide
anion and hydrogen peroxide, are important signaling
molecules in developing and proliferating cells, but also
in the induction of programmed cell death [10]. ROS
are transient species due to its high chemical reactivity
that leads to the LPO and a massive protein oxidation
and degradation [11, 12]. The author reported that ROS
cause DNA damage and strand breaks as a result of modi-
fying purines and pyrimidines bases by superoxide anion
radical (O2
•-), hydrogen peroxide (H2O2), and hydroxyl
radical (HO•).
Cedrelopsis grevei is an endemic species in Madagascar.
It was used in traditional medicine to treat malaria, fever
and fatigue [13]. Our previous study [14] showed that
sixty-four components were identified in C. grevei essen-
tial oil by GC-MS. The major constituents were: (E)-β-
farnesene (27.61 %), δ-cadinene (14.48 %), α-copaene
(7.65 %) and β -elemene (6.96 %). It exhibited antioxi-
dant activities and concentration-dependent inhibitory
effects on DPPH• and ABTS. Previous investigations of
the trunk [15] and stem [16] bark of C. grevei showed
that five coumarins i.e. norbraylin, methyl-O-cedrelopsin,
cedrecoumarin A, scoparone and braylin were isolated.
Atmaca et al. [17] showed that hepatoprotective effect of
coumarins against oxidative stress and liver damage in-
duced by carbon tetrachloride in male rats. In addition,
phenolic compounds of C. grevei are playing an essential
role in neutralizing free radical, quenching singlet and
triplet oxygen, decomposing peroxides, stabilizing lipid
peroxidation and protecting the cells against oxidative
damage [18].
Currently, some synthetic antioxidant use to prevent
free radical damage can induce side effects [19]. So, the
dietary intake of natural products is considered very
important for preventing a wide variety of diseases, in-
cluding allergies, cardiovascular disease, certain forms of
cancer, hepatic diseases, and inflammation, which involve
free radical–mediated damage in pathologically generating
processes [20]. Therefore, that is an essential research
about suitable herbal drugs, that could replace the chem-
ical ones [21]. However, the widespread use of C. grevei in
traditional medicine stimulated us to explore its potential
biological activity. To the best of our knowledge, no
previous study of the antioxidant and hepatoprotective
activities of C. grevei leaves extract have been reported.
Therefore, the current study was designed to evaluate
the antioxidant activity and hepatoprotective effect of C.
grevei leaves against Cyp induced oxidative stress, lipid
peroxidation and liver damage in male mice.
Materials and methods
Chemicals and reagents
The assay kits used for biochemical measurements of
aspartate aminotransferases (AST; EC 2.6.1.1.), alanine
aminotransferases (ALT; EC 2.6.1.2), alkaline phosphat-
ase (ALP; EC 3.1.3.1), lactate dehydrogenase (LDH; EC
1.1.1.27), catalase (CAT; EC 1.11.1.6), superoxide dismut-
ase (SOD; EC 1.15.1.1), glutathione-s-transferase (GST; EC
2.5.1.18), glutathione reduced (GSH), malondialdehyde
(MDA) and total protein were purchased from Biodiag-
nostic Company, Dokki, Giza, Egypt. Cypermethrin (95.1 %)
was obtained from Jiangsu Yangnong Chemical Co.,
Ltd, China. All other chemicals used were of analytical
reagent grade. All reagents were purchased from Sigma–
Aldrich–Fluka (Saint-Quentin France).
In vitro studies
Plant material and extraction
The leaves of C. grevei was collected from Toliara,
Madagascar and identified by Benja RAKOTONIRINA
(Institut malgache de recherches appliquées (IMRA),
Madagascar). A voucher specimen (No. TLR 07) was
deposited at the Herbarium of IMRA, Madagascar. The
leaves of C. grevei collected in Antananarivo, Madagascar
were ground to fine powder and successively extracted
with solvents of increasing polarity (cyclohexane, dichlo-
romethane, ethyl acetate, ethanol and finally methanol).
Thus, 200 g of leaves powder were placed in steeping with
cyclohexane (2 L) for 4 h under frequent agitation at
ambient temperature and pressure. The mixture was
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then filtrated using Wattman Paper (GF/A, 110 mm).
The solvent was evaporated by rotary evaporation under
vacuum at 30 °C. Then, the same powder extracted with
cyclohexane was extracted again with the next solvent, di-
chloromethane, under the same conditions. The same
protocol was applied for ethyl acetate, ethanol and metha-
nol. Extracts were subsequently stored in sealed and
amber vials at 4 °C for the following analysis.
Photochemical study
Determination of phenolic contents
The phenolic content of each extract was determined by
Folin-Ciocalteu method [22]. Briefly, a mixture of diluted
solution (20 μL) of each extract and 100 μL of Folin-
Ciocalteu reagent (0.2 N) were prepared. The mixture
was incubated for 5 min at room temperature and then
80 μL of sodium carbonate solution (75 g/L in water)
was added. The absorbance was read at 765 nm, after
1 h against water blank. A standard calibration curve was
plotted using gallic acid (0–300 mg/L). Results were
expressed as g of gallic acid equivalents (GAE)/ Kg of dry
mass.
Determination of flavonoids contents
The flavonoids were determined by Dowd method [22].
A mixture of diluted solution (100 μL) of each extract
and 100 μL of aluminum trichloride (AlCl3) in methanol
(2 %) were prepared. The absorbance of the mixture was
measured at 415 nm, after 15 min. At the same time, a
blank sample formed by methanol (100 μL) and extract
(100 μL) without AlCl3. The results were expressed as g
of quercetin equivalents (QE)/Kg of dry mass from cali-
bration curve.
Determination of anthocyanin content
The absorbance of the extract was measured at 510 and
700 nm in buffers at pH 1.0 (hydrochloric acid–potas-
sium chloride, 0.2 M) and 4.5 (acetic acid–sodium acetate,
1 M) [22] using 96-well plates. 20 μl extract solution was
mixed with 180 μl of buffers and the wavelength reading
was performed after 15 min of incubation. Anthocyanin
contents were calculated using a molar extinction coeffi-
cient (ε) of 29600 (cyanidin-3-glucoside) and absorbance
of A = [(A510 – A700) pH1.0 – (A510 – A700)pH4.5].
Determination of tannin content
Proanthocyanidins reactive to vanillin were analyzed by
the vanillin method [22]. One milliliter of extract solution
was placed in a test tube together with 2 mL of vanillin
(1 % in 7 M H2SO4) in an ice bath and then incubated at
25 °C. After 15 min, the absorbance of the solution was
read at 500 nm.
Antioxidant activity
The free radical scavenging activities by DPPH● and
ABTS•+ assays were evaluated according to the method
cited by Afoulous et al. [14]. Total reducing capacity of
C. grevei extracts was determined according to the method
of Oyaizu [23]. One mL of extract at different concentra-
tions (250–1000 μg/ml) were mixed with 2.5 ml phosphate
buffer (0.2 M, pH 6.6) and 2.5 mL potassium ferricyanide
[K3 Fe (CN)6] (1 %). The mixture was incubated at 50 °C
for 20 min, and then a portion (2.5 ml) of TCA (10 %) was
added to the mixture, which was centrifuged for 10 min at
1000 x g. The upper layer of solution (2.5 ml) was mixed
with distilled water (2.5 ml) and 0.5 mL FeCl3 (0.1 %).
Then the absorbance was measured at 700 nm. Ascorbic
acid (0.5-10 μg/ml) was used as the reference compound.
In vivo studies
Animals and treatments
Healthy adult male mice weighing 22.5 ± 1.0 g were ob-
tained from the Animal Breeding House of the National
Research Centre (NRC), Dokki, Giza, Egypt. Animals
were housed in clean plastic cages in the laboratory
animal room (23 ± 2 °C) on the standard pellet diet
and tap water ad-libitum, a minimum relative humidity of
40 % and a 12 h dark/light cycle. Mice were allowed to ac-
climate to laboratory conditions for 7 days prior to dosing.
The experimental work on mice was performed with the
approval of the Animal Care & Experimental Committee,
National Research Centre, Giza, Egypt, and international
guidelines for the care and use of laboratory animals.
Animals were randomly divided into six groups (six
mice each), control, Cyp, extract (150 and 300 mg/kg.
b.wt), Cyp plus extract (150 or 300 mg/kg. b.wt) groups.
Cyp and C. grevei extracts were administered by gavages
in a fixed volume of 0.1 ml/mice daily for 28 days. Cyp
was dissolved in corn oil and given via oral route at dose
13.8 mg/kg b.wt 1/10 LD50 [24]. C. grevei extracts were
dissolved in water and given via oral route at dose 150
and 300 mg/kg b.wt. Dosages were freshly prepared, ad-
justed weekly for body weight changes, while a control
group was received corn oil.
Sample collections
At the end of the experiment, blood samples were drawn
from the retro-orbital venous plexus of the animals in
glass tubes. Within 20 min of blood collection, the sera
were drawn after centrifugation at 3500 rpm for 10 min
at 4 °C. The sera were kept in a deep freezer (−20 °C)
for biochemical analysis. Portions of liver from all animals
in each group were homogenized in 50 mM Tris–HCl
buffer (pH 7.4) containing 1.15 % potassium chloride. The
homogenates were centrifuged at 10,000 g for 15 min
at 4 °C. The collected supernatants were used for the
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estimation of the activities of CAT, SOD, GST enzymes
and the contents of GSH and LPO.
Body weights and relative liver weights
During the experimental period, body weight changes of
male mice were recorded weekly. At the end of treatments,
the mice were sacrificed by cervical dislocation. Liver of
mice was quickly removed, cleaned, weighed and used for
biochemical and histological studies. Then, relative weight
of liver was calculated.
Biochemical measurements
All biochemical measurements (AST, ALT, ALP, LDH,
SOD, CAT, GST, MDA, and GSH) were determined using
commercial kits in accordance with manufacturers’ in-
structions using a spectrophotometer (Shimadzu UV–VIS
Recording 2401, PC, Japan).
Histological study
Small pieces of liver samples from each group were dis-
sected and fixed in 10 % neutral formalin, dehydrated in
ascending grades of alcohol and embedded in paraffin
wax. Paraffin sections (5 μm thick) were stained for routine
histological study using haematoxylin and eosin (H&E).
Two slides were prepared for each mice; each slid content
two sections. Ten field areas for each section were selected
and examined for histopathological changes (x160) under
light microscope. According to Michael [25], the liver
fields were scored as follows: normal appearance (−), min-
imal cellular disruption in less than 1 % of field area (+),
mild cellular disruption of 1-30 % of field area (++), mod-
erate cellular disruption of 31-60 % of field area (+++), se-
vere cell disruption of 61-90 % of field area (++++) and
very severe cellular disruption of 91-100 % of field area
(++++).
Statistical analysis
The results were expressed as means ± S.D. All data were
done with the Statistical Package for Social Sciences (SPSS
17.0 for windows). The results were analyzed using one
way analysis of variance (ANOVA) followed by Duncan’s
test for comparison between different treatment groups.
Statistical significance was set at P ≤ 0.05.
Results
The highest yield of C. grevei was obtained with the di-
chloromethane extract (4.6 %) of the plant material.
While, the low yield was observed with the ethyl acetate
extract (0.44 %). This variation in the yields of different
extracts can be explained by the difference of polarity for
compounds present in the plant (Table 1). Methanolic and
ethanolic extracts of C. grevei were found to have high
total phenolic content, 41.67 ± 0.19 and 39.12 ± 0.44 g
GAE/Kg ES, respectively (Table 2). So, in the present
study, the polar extracts containing the highest amount
of phenolic (EtOH and MeOH) were selected for the fur-
ther analysis. The ethanol extract is the richest by tannins
with 22.14 ± 1.03 g EC/kg ES, followed by methanol ex-
tract with 12.69 ± 0.63 g EC/Kg ES. The ethanolic and
methanol extracts have obtained intermediate values for
anthocyanins (respectively 1.86 ± 0.13 and 1.35 ± 0.08 g
C3GE/Kg ES) (Table 2), while flavonoids not detected.
Figure 1 illustrates a decrease in the concentration of
DPPH radical due to the scavenging ability of C. grevei
extracts. On DPPH radical, EtOH and MeOH had scav-
enging effects with increasing concentration in the range
of 95–400 μg/mL, and the scavenging effect of EtOH
was lower than MeOH. The IC50 value of ascorbic acid
was 4.7 μg/mL. MeOH extract (400 μg/mL) exhibited
the highest inhibition of about 69.45 %, but this is lower
in EtOH extract whose percentage of inhibition is 61.27 %.
ABTS assay is shown in Fig. 2. C. grevei extracts (100 μg/
mL) exhibited the highest inhibition of 76.81 % and
78.35 % of MeOH and EtOH extracts. As illustrated in
Fig. 3, Fe3+ was transformed to Fe2+ in the presence of
MeOH and EtOH extracts of C. grevei to measure the
reductive capability. C. grevei extracts had significant in-
hibition of reducing power with increasing concentration
in the range of 0.10-0.125 mg/mL.
In the present study, the body weight loss was mark-
edly observed of mice treated with Cyp compared to the
control group (Fig. 4A). The difference between the two
groups was statistically significant (30.38 g vs. 32.82 g,
Table 1 Solvents extract and yield of Cedrelpsis grevei
Solvents Cyclohexane Dichloromethane Acetate ethyl Ethanol Methanol
N 1 3 2 2 1
Yield (g/100 g) 2.1 4.6 0.44 2.2 0.8
N, number of extractions; C. grevei leaves weights 200 g dry weight; solvent = 2 liter; extraction after 4h of steeping
Table 2 Chemical composition of C. grevei leaves extracts
Extract Phenolics (g GAE/Kg ES) Flavonoids (g QE/Kg ES) Tannins (g CE/Kg ES) Anthocyanins (g C3GE/Kg ES)
Ethanol 39.12±0.44b nd 22.14±1.03a 1.86±0.13b
Methanol 41.67±0.19a nd 12.69±0.63b 1.35±0.08d
Nd: not detected
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P ≤ 0.05). Co- administration of C. grevei (MeOH extract)
at 300 mg/kg b.wt. to mice of Cyp group restored body
weight to normal range (33.81 g vs. 32.82 g). As shown in
Fig. 4B, significant decrease in relative liver weight was ob-
served after treatment of mice with Cyp compared to con-
trol group (5.44 % g vs. 4.88 % g). Co-administration of C.
grevei at 150 & 300 mg/kg b.wt. with Cyp modulated sig-
nificantly relative live weight to the normal control value
(4.98 %, 4.91 % vs. 4.88 %).
The oral administration of the two tested doses of C.
grevei extract (150 & 300 mg/kg/day) to normal mice pro-
duced no changes in all serum biochemical parameters of
liver compared to the normal control mice (Table 3). In
contrast, male mice exposed to Cyp (13.80 mg/kg/day) in-
duced a severe hepatic damage in serum enzyme activities
of ALT, AST and ALP levels comparable to control
(Table 3). Also in Cyp-treated mice, serum LDH activity
was increased by 37.53 %, while it was decreased by
−27.84 % in the liver homogenate. However, co-
administration of C. grevei extract to Cyp-treated mice
resulted in a partial recovery in the above-mentioned pa-
rameters (AST, ALT, ALP and LDH) in a dose dependent
manner. The high dose of C. grevei extract (300 mg/kg)
was more effective than low dose (150 mg/kg) to attenuate
the perturbations in the tested enzymes (Table 3).
In the liver homogenates of Cyp-treated mice, the ac-
tivities of SOD, CAT, GST and the level of GSH de-
creased significantly (P ≤ 0.05) by 20.5 %, 38.5 %, 18.6 %
and 30.1 %, respectively, while the level of MDA increased
significantly (P ≤ 0.05) by 51.0 % when compared to the
corresponding controls (Table 4). In this study, MDA level
increased in mice exposed to Cyp. Co-administration of
C. grevei extract to Cyp-treated mice resulted in a partial
recovery in the above-mentioned parameters in a dose
dependent manner. The high dose of C. grevei extract
(300 mg/kg) was more effective than low dose (150 mg/kg)
to attenuate the perturbations in the tested enzymes
(Table 4).
The representative picutures of histopathological exam-
ination of the liver tissue are shown in Fig. 5 (A-D) and
Fig. 1 DPPH radical scavenging activity (%) of MeOH and EthOH extracts of C. grevei. Bars represent the mean ± SD
Fig. 2 ABTS•+ Scavenging activity (%) of MeOH and EthOH extracts of C. grevei. Bars represent the mean ± SD
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Fig. 3 Reducing power (absorbance at 700 nm) of MeOH and EthOH extracts of C. grevei. Values are mean ± SD
Fig. 4 Body (a) and relative liver (b) weights of rats exposed to cypermethrin (Cyp) and the protective effect of C. grevei (MeOH extract). Bars represent the
mean of 6 mice ± SD; values are not sharing superscripts letters (a, b, c, d, e) differ significantly at P≤ 0.05. Relative liver weight (%) = (liver weight/body
weight) X 100. Con: control; Cyp: cypermethrin; Ext 150: 150 mg/kg b.wt of C. grevei extract; Ext 300: 300 mg/kg b.wt of C. grevei extract (MeOH extract)
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the semi quantitative histological scoring of liver damage
is presented in Table 5. Liver sections from the control
group mice showed normal hepatic cytoarchitecture. They
formed of hepatocytes radiating from central vein to the
periphery of the lobules (Fig. 5A). Liver lobules of Cyp-
treated mice showed severe degeneration in hepatocytes,
necroses, dilation of portal vein with inflammatory cell
infiltration in the portal area (Fig. 5B). Liver sections of
mice treated with Cyp + Ext 150 (Fig. 5C) showed mild
to moderate dilatation of central vein and ballooning
degeneration in surrounding hepatocytes. Whereas, in
cypermethrin + Ext 300 treated mice (Fig. 5C) showed
only moderate dilatation of portal vein.
Discussion
The natural antioxidants present in many plants reduce
oxidative damage and help prevent mutagenesis, carcino-
genesis and aging due to their radical scavenging activities
[8, 20]. Therefore, phenolic compounds of plants are very
important because their hydroxyl groups confer anti-
oxidant activity. Results of the present study showed
that phenolics content of methanol and ethanol extract
of C. grevei were similar quantities. However, no work in
the literature cited the quantification of phenolic com-
pound of that family. We have not detected flavonoids.
These results are contradictory to those presented by the
study of Paris and Debray [26], which showed that the
leaves of C. grevei contain 2 % flavonoids as glycosides of
flavonols. The ethanol extract is the richest by tannins,
followed by methanol extract. In addition, the ethanolic
and methanol extracts have obtained intermediate values
for anthocyanins [26].
Free radicals are continuously produced in body and
cause the oxidation of biomolecules (e.g., protein, amino
acids, lipid and DNA) which leads to cell injury and death.
Our results revealed that EtOH and MeOH extract of C.
grevei had DPPH scavenging activity in a concentration
depending manner. C. grevei extracts (100 μg/mL) exhib-
ited the highest inhibition of ABTS. In reducing power
assay, Fe3+ was transformed to Fe2+ in the presence of
MeOH and EtOH extracts of C. grevei to measure the re-
ductive capability. C. grevei extracts had significant inhib-
ition of reducing power with increasing concentration in
the range of 0.10-0.125 mg/mL. The result obtained by
this method confirms those of tests DPPH and ABTS.
In toxicological studies, changes in the body weight and
relative organs weights are important criteria for evaluation
of organ toxicity and were used as a valuable index of
insecticide-related organ damage [8]. Liver is the first
organ to face any foreign molecule that is carried through
portal circulation and it is subjected to most damage. It
has been previously reported that during liver damage
Table 3 Effect of C. grevei MeOH extract on SOD, CAT, GST, LPO and GSH in liver of mice exposed to cypermethrin
Treatments SOD(U/g tissue)) CAT(U/g tissue) GST(U/g tissue) LPO(nmol/g tissue) GSH(mmol/g tissue)
Control 664.20±8.58c 298.68±4.47c 2018.51±63.92c 295.42±8.12a 155.11±3.02c
Ext 150 668.74±17.49c 292.59±8.34c 2093.45±31.66c 298.03±9.45a 157.18±2.85c
Ext 300 676.82±20.47c 297.95±5.17c 2157.52±32.78c 292.38±7.25a 159.99±3.07c
Cyp 527.93±19.46a 183.67±6.38a 1642.73±52.93a 446.19±13.78c 108.48±3.93a
Cyp+ Ext 150 609.69±17.84b 272.15±6.78b 1710.54±53.95ab 409.15±20.25c 120.03±6.18a
Cyp+ Ext 300 632.40±22.02bc 287.87±9.92bc 1808.70±52.66b 369.50±14.58b 135.57±4.39b
Each value is a mean of 6 animals ± SD.; a, b, c, dvalues are not shared superscripts letters (a, b, c, d) differ significantly at P≤ 0.05; Con: control; Cyp: cypermethrin;
Ext 150 & Ext 300; 150 and 300 mg/ kg b.wt of C. grevei extract. SOD: superoxide dismutase; CAT: catalase; GST: glutathione-S-transferase; LPO: lipid peroxidation;
GSH: glutathione reduced
Table 4 Effect of C. grevei MeOH extract on the activity of ALT, AST, ALP and LDH in serum and LDH in liver homogenate of mice
exposed to cypermethrin
Treatments ALT AST ALP LDH
(U/L) (U/L) (U/L) Serum(U/L) Liver(U/g tissue)
Control 44.36±0.92a 53.33±0.32a 89.88±1.77a 176.83±6.96a 158.30±11.83b
Ext 150 45.23±0.92a 52.82±0.24a 90.97±1.29a 172.87±8.38a 160.55±10.32b
Ext 300 43.84±1.02a 53.45±0.57a 88.99±1.80a 178.32±10.05a 161.90±8.98b
Cyp 60.62±1.43c 69.39±2.33c 131.45±3.32d 243.21±8.23c 114.23±4.86a
Cyp+ Ext 150 55.88±1.26b 63.88±1.32b 113.84±3.05c 222.61±8.95bc 115.04±4.91a
Cyp+ Ext 300 53.16±1.18b 60.70±2.23b 103.10±2.25b 203.32±7.88b 133.12±2.92a
Each value is a mean of 6 animals ± S.E.; a, b, c, dvalues are not shared superscripts letters (a, b, c, d) differ significantly at P≤ 0.05; Con: control; Cyp: cypermethrin;
Ext 150 & Ext 300; 150 and 300 mg/ kg b.wt of C. grevei MeOH extract. ALT: alanine aminotransferases; AST: aspartate aminotransferases; ALP: alkaline phosphatase;
LDH: lactate dehydrogenase
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there was an observed decrease in antioxidant defenses
in the liver [26]. In the present study, the body weights
of mice treated with Cyp was markedly less while rela-
tive liver weight was increased compared to the control
group. Administration of C. grevei extract at 300 mg/kg
b.wt. to Cyp-intoxicated mice restored body weight to
normal range and modulated significantly relative live
weight to the normal control value. The decrease in
body weight of Cyp treated mice was considered the re-
sult of direct toxicity and/or indirect toxicity related to
the liver damage [27–29]. It may be attributed to the ef-
fect of insecticides on gastrointestinal tract resulting in
decreased appetite and absorption of nutrients from gut
[30]. Other investigations have reported the reduction in
body weight and change in relative organs weights in
Cyp-treated rats [31, 32] and in rabbits [33]
Cyp treatment induced a severe hepatic damage in
serum enzyme activities of ALT, AST, ALP and LDH of
male mice. The increase in serum AST, ALT and ALP en-
zymes may be due to liver dysfunction and disturbance in
the biosynthesis of these enzymes with alteration in the
permeability of the liver membrane takes place [34]. The
increase in serum LDH activity may be due to the hepato-
cellular necrosis leading to leakage of the enzyme into the
blood stream [35]. However, co-administration of C. grevei
extract to Cyp-treated mice resulted in a partial recovery
in the above-mentioned parameters (AST, ALT, ALP and
LDH). The high dose of C. grevei extract (300 mg/kg) was
more effective than low dose (150 mg/kg) to attenuate the
perturbations in the tested enzymes.
SOD and CAT are known to play an important role in
scavenging ROS. SOD catalyzes the destruction of the
superoxide radicals to H2O2, while CAT reduces the
H2O2 into water and oxygen to prevent oxidative stress
and in maintaining cell homeostasis. In addition, GST play
essential role in the detoxification process. In the liver
homogenates of Cyp-treated mice, the activities of SOD,
CAT, GST and the level of GSH decreased significantly,
while the level of LPO increased significantly. The change
in SOD and CAT might be in response to increased oxida-
tive stress. Considering that GST are detoxifying enzymes
that catalyze the conjugation of a variety of electrophilic
substrates to the thiol group of GSH, producing less toxic
forms [36], the significant decrease of GST activity may in-
dicate insufficient detoxification of Cyp in intoxicated
mice.
Malondialdehyde (MDA) is a major oxidation product
of peroxidized polyunsaturated fatty acids and increased
MDA content is an important indicator of lipid peroxida-
tion (LPO) [37]. In the present study, MDA level increased
in mice exposed to Cyp. However, when a condition of
oxidative stress strongly establishes, the defense capacities
Fig. 5 Paraffin sections of liver stained by haematoxylin and eosin (H&E)
for histopathological changes. Control group and extract groups [A]
showing the normal histological structure of the central vein (CV) and
surrounding hepatocytes (H) (x40). Cypermethrin group showing [B]
degeneration in hepatocytes and dilation of portal vein with
inflammatory cells infiltration (m) in the portal area (x80). Cypermethrin
plus extract at 150 mg/kg. b.wt. [C] showing dilatation of central vein
(CV) ballooning degeneration (h) in surrounding hepatocytes (x80).
Cypermethrin plus extract at 300 mg/kg. b.wt. [D] showing dilatation
of portal vein (x80)
Table 5 The severity of the reaction in liver tissue of different groups according to the histopathological alterations.
Histopathological alterations Treatment
Con Ext 150 Ext 300 Cyp Cyp+ Ext 150 Cyp+ Ext 300
Inflammatory cell infiltration in portal area - - - +++ - -
Inflammatory cell infiltration in hepatic parenchyma - - - +++ - -
Degeneration in hepatocytes - - - ++++ ++ -
Congestion in portal vein - - - ++++ - ++
Congestion in central vein - - - +++ + -
Con: control; Cyp: cypermethrin; Ext 150 & Ext 300; 150 and 300 mg/ kg b.wt of C. grevei MeOH extract. ++++ Very sever; +++ Sever; ++ moderate; + mild; - nil
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against ROS becomes insufficient, in turn ROS also affect
the antioxidant defense mechanisms, reduces the intracel-
lular concentration of GSH, alters the activity of antioxi-
dant enzymes e.g., SOD & CAT and increase MDA. These
indirectly suggest an increased production of oxygen free
radicals in mice. Highly reactive oxygen metabolites, espe-
cially hydroxyl radicals, act on unsaturated fatty acids
of phospholipid components of membranes to produce
malondialdehyde, an LPO product [38]. However, co-
administration of C. grevei extract to Cyp-treated mice
resulted in a partial recovery in the above-mentioned
parameters in a dose dependent manner.
The histopathological changes in liver showed that ex-
posure of mice to Cyp resulted in degenerative changes
in the liver, including degeneration, necrosis, and inflam-
matory cells in the portal area. The biomarkers of liver
dysfunction corroborated with the histopathological le-
sions observed in the current study. These observations
indicated marked changes in the overall histoarchitec-
ture of liver in response to Cyp, which could be due to
its toxic effects primarily by the generation of reactive
oxygen species causing damage to the various membrane
components of the cell. Co-administration of C. grevei
extract showed marked improvement in its histological
structure in comparison to Cyp-treated group alone and
represented by nil to moderate degree in inflammatory
cell infiltration in portal area, degeneration in hepatocytes
and congestion in the portal vein and central vein.
The present study has demonstrated that C. grevei
exert have a hepatoprotective effect against Cyp-induced
oxidative damage and hepatotoxicity in mice. Normalized
antioxidant enzymes and reduction in MDA level are
likely to be the major mechanisms by which C. grevei
prevented development of the liver damage. Supporting
this hypothesis, we observed significant increases in
SOD, CAT, and GST enzyme activity and decreases in
the levels of MDA in liver tissue concomitant with in-
significant changes in liver serum dysfunction biomarkers
(AST, ALT, ALP and LDH) of Cyp-treated mice by the
administration of C grevei especially at high dose (300 mg/
kg/day). This might be due to the antioxidant activity and
hydroxyl radical scavenging effect of C. grevei, which
sported by DPPH, ABTS scavenging activity and redu-
cing power measurements. However, the antioxidant ac-
tivity of an antioxidant compound have been attributed
to various mechanisms, among which are prevention of
chain initiation, binding of transition metal ion catalysts,
decomposition of peroxides, prevention of continued
hydrogen abstraction, reductive capacity and radical scav-
enging [38].
Conclusion
In view of the data of the present study, it can deduce
that Cyp caused oxidative damage and liver dysfunction
in male mice. C. grevei extract has protective effects on
Cyp-induced lipid peroxidation, oxidative stress and liver
damage. C. grevei was found to be an effective antioxi-
dant in many in vitro assays such as DPPH, ABTS and
reducing power. These results indicated that administra-
tion of C. grevei is useful, easy, and economical to protect
humans against pesticides toxicity. The results presented
here can be considered as the first information on the
hepatoprotective and antioxidant properties of C. grevei
extracts.
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